Tactile secures coding for Nimbl 

MINNEAPOLIS – Tactile Systems has announced that the Pricing, Data Analysis and Coding (PDAC) contractor for CMS has approved the use of HCPCS code E0651 to bill for its Nimbl pneumonia compression platform. The PDAC’s approval follows the company’s 510(k) clearance from the U.S. Food and Drug Administration in June. “The receipt of PDAC approval for Nimbl comes earlier than expected, and we are pleased that CMS recognizes the potential health and quality-of-life enhancing benefits this device offers for Medicare patients struggling with lymphedema and chronic venous insufficiency,” said Sheri Dodd, CE at Tactile Medical. “Nimbl’s new sleeker design and technical advancements reflect our commitment to meaningful product innovation that seeks to meet the patient wherever they are in the treatment pathway. I am proud of the work our team has accomplished in developing this new platform, which I believe will elevate lymphedema therapy and increase patient acceptance and adherence.” Tactile Medical plans to make Nimbl commercially available in the U.S. in the coming weeks. The device is the next generation of the company’s basic lymphedema compression solution and is indicated for the treatment of lymphedema, chronic edema, venous insufficiency and wound healing. The company says it features several key patient-friendly enhancements over prior generations, including a 40% and 68% reduction in size and weight, respectively, making it more portable and ideal for active lifestyles. Nimbl also offers connectivity to the company’s Kylee digital application, enabling patients to actively track their therapy progress and share results with their care team.